High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism

被引:200
作者
Kawase, Takakazu
Morishima, Yasuo
Matsuo, Keitaro
Kashiwase, Koichi
Inoko, Hidetoshi
Saji, Hiroh
Kato, Shunichi
Juji, Takeo
Kodera, Yoshihisa
Sasazuki, Takehiko
机构
[1] Aichi Canc Ctr, Dept Hematol & Cell Therapy, Chikusa Ku, Nagoya, Aichi 4648681, Japan
[2] Aichi Canc Ctr, Div Immunol, Nagoya, Aichi 4648681, Japan
[3] Aichi Canc Ctr, Div Epidemiol & Prevent, Nagoya, Aichi 4648681, Japan
[4] Japanese Red Cross Tokyo Metropolitan Blood Ctr, Tokyo, Japan
[5] Tokai Univ, Sch Med, Div Mol Sci, Isehara, Kanagawa 25911, Japan
[6] Nonprofit Org, HLA Lab, Kyoto, Japan
[7] Tokai Univ, Sch Med, Dept Cell Transplanatat & Regenerat Med, Isehara, Kanagawa 25911, Japan
[8] Japanese Red Cross Cent Blood Inst, Tokyo, Japan
[9] Japanese Red Cross Nagoya First Hosp, Nagoya, Aichi, Japan
[10] Int Med Ctr Japan, Tokyo, Japan
关键词
D O I
10.1182/blood-2007-02-072405
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In allogenic hematopoietic stem-cell transplantation, an effect of HLA locus mismatch in affele level on clinical outcome has been clarified. However, the effect of each HLA allele mismatch combination is little known, and its molecular mechanism to induce acute graftversus-host disease (aGVHD) remains to be elucidated. A total of 5210 donor patient pairs who underwent transplantation through Japan Marrow Donor Program were analyzed. All HLA-A, -B, -C, -DRB1, -DQB1, and -DPB1 alleles were retrospectively typed in all pairs. The impacts of the HLA allele mismatch combinations and amino acid substitution positions in 6 HLA loci on severe aGVHD were analyzed. A total of 15 significant high-risk HLA allele mismatch combinations and 1 HLA-DRBl-DQB1 linked mismatch combinations (high-risk mismatch) for severe aGVHD were identified, and the number of high-risk mismatches was highly associated with the occurrence of severe aGVHD regardless of the presence of mismatch combinations other than high-risk mismatch. Furthermore, 6 specific amino acid substitution positions in HLA class I were identified as those responsible for severe aGVHD. These findings provide evidence to elucidate the mechanism of aGVHD on the basis of HLA molecule. Furthermore, the identification of highrisk mismatch, that is, nonpermissive mismatch, would be beneficial for the selection of a suitable donor.
引用
收藏
页码:2235 / 2241
页数:7
相关论文
共 33 条
[1]  
BIRO JC, AMINO ACID SIZE CHAR
[2]   STRUCTURE OF THE HUMAN CLASS-I HISTOCOMPATIBILITY ANTIGEN, HLA-A2 [J].
BJORKMAN, PJ ;
SAPER, MA ;
SAMRAOUI, B ;
BENNETT, WS ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1987, 329 (6139) :506-512
[3]   Cumulative incidence estimation in the presence of competing risks [J].
Coviello, Vincenzo ;
Boggess, May .
STATA JOURNAL, 2004, 4 (02) :103-112
[4]  
COX DR, 1972, J R STAT SOC B, V34, P187
[5]  
Davies SM, 2000, BLOOD, V96, P4096
[6]   1977 RIETZ LECTURE - BOOTSTRAP METHODS - ANOTHER LOOK AT THE JACKKNIFE [J].
EFRON, B .
ANNALS OF STATISTICS, 1979, 7 (01) :1-26
[7]   Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain [J].
Ferrara, GB ;
Bacigalupo, A ;
Lamparelli, T ;
Lanino, E ;
Delfino, L ;
Morabito, A ;
Parodi, AM ;
Pera, C ;
Pozzi, S ;
Sormani, MP ;
Bruzzi, P ;
Bordo, D ;
Bolognesi, M ;
Bandini, G ;
Bontadini, A ;
Barbanti, M ;
Frumento, G .
BLOOD, 2001, 98 (10) :3150-3155
[8]   Graft rejection after unrelated donor hematopoietic stera cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction [J].
Fleischhauer, K ;
Locatelli, F ;
Zecca, M ;
Orofino, MG ;
Giardini, C ;
de Stefano, P ;
Pession, A ;
Iannone, AM ;
Carcassi, C ;
Zino, E ;
La Nasa, G .
BLOOD, 2006, 107 (07) :2984-2992
[9]   Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome [J].
Flomenberg, N ;
Baxter-Lowe, LA ;
Confer, D ;
Fernandez-Vina, M ;
Filipovich, A ;
Horowitz, M ;
Hurley, C ;
Kollman, C ;
Anasetti, C ;
Noreen, H ;
Begovich, A ;
Hildebrand, W ;
Petersdorf, E ;
Schmeckpeper, B ;
Setterholm, M ;
Trachtenberg, E ;
Williams, T ;
Yunis, E ;
Weisdorf, D .
BLOOD, 2004, 104 (07) :1923-1930
[10]  
Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO